The results from the xenograft tumor model revealed that injection of H. pylori-pretreated BM-MSCs dramatically increased the growth of GC subcutaneous tumors, and these effects were also notably inhibited when THBS4 was silenced (Figure 6A–6D). Here, THBS4 is linked to gastric cancer.